Therapeutic Programs

Aileron has been able to rapidly advance multiple Stapled Peptide programs and has built a broad and growing drug candidate pipeline across a host of therapeutic areas. Aileron and its collaborators are progressing programs across multiple disease areas including cancer, infectious disease, metabolic disease and immune/inflammatory diseases. Thus far, the preclinical data Aileron has generated has been compelling. At the 2008 American Association for Clinical Cancer Research (AACR) annual meeting, Aileron presented preclinical data showing excellent in vitro and in vivo efficacies for Stapled Peptide Therapeutics in multiple cancer models.